A Double-Blind, Randomised, Cross-over, Safety and Efficacy Pilot Study Comparing Two Botulinum Toxin Type-A Products in the Treatment of Moderate to Severe Cervical Dystonia

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-006169-15

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary Objective To compare the efficacy of intramuscular BOTOX® versus Xeomin® in the treatment of moderate to severe cervical dystonia.


Critère d'inclusion

  • Cervical dystonia is the most common form of focal dystonia prevalent at a rate of 89 per million individuals. Sustained involuntary contractions of the neck muscles, lead to painful and disabling neck spasms with abnormal postures of the head

Liens